Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ January 28, 2023 ] TYR Sport Signs Prodigy Katie Grimes. Los Angeles Biotech News
  • [ January 27, 2023 ] Ayal Willner, MD, is recognized by Continental Who’s Who Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15(c) Announcement – Rule 15 Proposal to Horizon Equity Award Holders and Participants in the Horizon Employee Share Purchase Plan Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15 (c) Announcement – Horizon Therapeutics plc Los Angeles Biotech News
  • [ January 27, 2023 ] Research Technician I – Zymo Research – Irvine, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsMateon Provides Update on OT-101

Mateon Provides Update on OT-101

June 1, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Mateon Provides Update on OT-101

AGOURA HILLS, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc.  (OTCQB:MATN) report several peer-reviewed publications derived from its R&D effort against COVID-19.

Click to view original post

Previous

ChromaDex to Host Symposium on NAD+ in Human Health and Disease at NUTRITION 2020 LIVE ONLINE Annual Meeting

Next

HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered